Navigation Links
NWO/Spinoza Prize for literature, microbiology, physics and medicine
Date:6/2/2008

INOZA PRIZES 2008

Jury report for Prof. W.M. (Willem) de Vos
Professor of Microbiology at Wageningen University

Professor De Vos receives the NWO/Spinoza Prize 2008 for his groundbreaking research into the contribution of microorganisms such as bacteria to human food and health.

Willem M. de Vos (30 October 1954, Apeldoorn) obtained a master's degree in biology/biochemistry with distinction from the University of Groningen in 1978, where he subsequently gained his doctorate with distinction in 1983 for research that was partly carried out at the Max Planck Institute for Molecular Genetics in Berlin. After a postdoctoral position in England, he started a research group at the Netherlands Institute for Dairy Research (now NIZO Food Research), where he became research manager in 1987. In that same year, Wageningen University appointed him as part-time professor of Bacterial Genetics and in 1994 he became full-time professor and chair of Microbiology. He has combined this chair with various directorships at the University and at scientific institutes, such as the Top Institute Food & Nutrition. Since 2007 he also holds a part-time position as Finland Distinguished Professor at the University of Helsinki.

De Vos is a leading expert in the molecular genetics of microorganisms, such as bacteria, archaea and fungi. For example, he has discovered that lactic acid bacteria communicate with each other by means of special peptides and that by producing these peptides they can even interfere with the growth of other microorganisms. He has also developed methods to specifically influence the metabolism of lactic acid bacteria so that the production of flavours, vitamins and sweeteners can be improved. His fundamental discoveries are applied on a large scale. His research has led to the development of lactic acid bacteria that can improve the taste and shelf life of cheese.

He was the first to use a multidisciplinary approach to e
'/>"/>

Contact: NWO, Department of Information and Communication
voorlichting@nwo.nl
31-703-440-713
Netherlands Organization for Scientific Research
Source:Eurekalert

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine news :

1. Kavli Prize awarded to Pasko Rakic, pioneering Yale neuroscientist
2. Worcester Polytechnic Institute announces 2008 Chairmans Exemplary Faculty Prize winners
3. Summit VetPharm Announces Grand Prize and March Winner in its Great Vectra 3D(TM) $125,000 Giveaway
4. Computer games high score could earn the Nobel Prize in medicine
5. March of Dimes awards $250,000 prize to leaders in understanding embryonic development
6. U.S. Scientists Receive Japan Prize on April 23, 2008
7. Xoft Medical Director Recognized by Gotham Prize for Cancer Research
8. Pollin Pediatric Research Prize awarded for discovery of lifesaving treatment of RDS
9. Prize or patent? Innovative ideas for funding medical drug development and access
10. Virginia Beach Man Loses 17 Pounds, on Top of a Previous 100 Pound Loss, and Wins Major $50,000 Prize
11. Whole Planet Foundation(TM) (a Whole Foods Market Foundation) and Nobel Peace Prize Winner Dr. Muhammad Yunus Partner With Natural Foods Vendors, Pledging Over $1 Million to Help Combat Poverty
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2008)...ent Highlights Women,s Unmet Needs for HIV Prevent...n Family Planning Methods , , (Para tener a...stellano, vaya al sitio www.preventionnow.net .) ...nternational coalition of organizations that repre...United States is demanding increased access to the...
(Date:12/1/2008)...HONORED FOR CAREER OF SCIENTIFIC DISCOVERY IN MOLE...RNewswire/ -- The Radiologic Society of North Amer... its "Outstanding Researcher of The Year" Award, r...has made original significant contributions to the...h. Dr. Weissleder is Professor at Harvard Medical...
(Date:12/1/2008)... Zimmer Holdings, Inc.,(...ry A. McCaulley has joined the,Company as Preside...ility for,the Company,s activities in the reconst...g and Americas Sales. Mr. McCaulley will report t...ef Executive Officer. , "Jeff has a tremend...
(Date:12/1/2008)...PRNewswire/ -- One of America,s leading plastic,s...aking technique for inner,vaginal lip reduction k...ective. His study is published in the December 20... the official medical journal of the American Soci...er lip) reduction or labioplasty,is the most comm...
Breaking Medicine News(10 mins):Health News:Latin American and U.S. Latina Women Unite to Demand Access to the Female Condom 2Health News:Latin American and U.S. Latina Women Unite to Demand Access to the Female Condom 3Health News:VisEn Co-Founder Named Radiologic Society's 'Outstanding Researcher of the Year' 2Health News:VisEn Co-Founder Named Radiologic Society's 'Outstanding Researcher of the Year' 3Health News:Zimmer Holdings Names Jeffery A. McCaulley President, Zimmer Reconstructive 2Health News:Zimmer Holdings Names Jeffery A. McCaulley President, Zimmer Reconstructive 3Health News:Plastic Surgery Journal Shows New Groundbreaking Genital Cosmetic Procedure for Women to be Successful 2
...ntries like Indonesia, the Unjted Nations health b...mised efforts would be made to ensure "fair and eq...s at affordable prices in the event of a pandemic....untries agreed to "timely sharing of viruses" with...
...oon on Monday at a meeting of the U.N. General Ass...S pandemic said he believes it is possible to hal...espite the increasing number of cases worldwide. ...wed pledges and set new targets to provide univers...
...entists has shown that a compound extracted from a...o reduce craving for marihuana, and block its effe...d based National Institute on Drug Abuse found tha...xtract, the rodents lose their hankering for a syn...
...ednesday the possibility that a resident of a prov...cted the lethal H5N1 strain of the bird flu virus,...k of bird flu has hit five provinces in Vietnam. A... lethal H5N1 strain after being hospitalized in se...
Other Medicine News:Health News:WHO Announces Deal on Sharing Bird Flu Virus 2Health News:U.N. Secretary-General Ban Renews Goal To Reverse Spread of HIV by 2015 2Health News:Compound Present in Plant may Help to Curb Craving for Cannabis 2
(Date:11/26/2008)...n., Nov. 26 Children wh...ignificantly increased risk of developing mental i...f a Mayo Clinic study published this month in Ped...demy of Pediatrics. , , The retrospective s...with strabismus (misaligned eyes) and compared the...
(Date:11/25/2008)... most respondents against expanding statin use bro...TLE FALLS, N.J., Nov. 25 JUPITER, ... the cardiovascular risk of healthy patients with ...se in older adults, according to a national poll d...ipants took part in the online poll conducted by m...
(Date:11/25/2008).... 25 CardioVascular,Bio...ounced today that it has,dosed the first patient ...I,clinical trial to treat patients with severe co... the treatment of CORonary heart Disease) trial wi...-controlled doses in approximately 120,patients w...
(Date:11/24/2008)...rms its innovation leadership and long-term commit...N.J., Nov. 24 Schering-P...clinical update on boceprevir, its lead investigat...y in Phase III development. The company believes ...s and best-in-class protease inhibitor for treatin...
Breaking Medicine Technology:Eye Divergence in Children Triples Risk of Mental Illness 2Dramatic JUPITER Findings Fail to Sway Prescribing Behavior, Poll Shows 2Dramatic JUPITER Findings Fail to Sway Prescribing Behavior, Poll Shows 3CVBT Doses First Patient in its Phase II Clinical Trial for Severe Coronary Heart Disease 2CVBT Doses First Patient in its Phase II Clinical Trial for Severe Coronary Heart Disease 3Schering-Plough Provides Update on Boceprevir Clinical Development and Introduces Potent Next-Generation Oral HCV Protease Inhibitor for Treating Patients With Chronic Hepatitis C 2Schering-Plough Provides Update on Boceprevir Clinical Development and Introduces Potent Next-Generation Oral HCV Protease Inhibitor for Treating Patients With Chronic Hepatitis C 3Schering-Plough Provides Update on Boceprevir Clinical Development and Introduces Potent Next-Generation Oral HCV Protease Inhibitor for Treating Patients With Chronic Hepatitis C 4Schering-Plough Provides Update on Boceprevir Clinical Development and Introduces Potent Next-Generation Oral HCV Protease Inhibitor for Treating Patients With Chronic Hepatitis C 5Schering-Plough Provides Update on Boceprevir Clinical Development and Introduces Potent Next-Generation Oral HCV Protease Inhibitor for Treating Patients With Chronic Hepatitis C 6Schering-Plough Provides Update on Boceprevir Clinical Development and Introduces Potent Next-Generation Oral HCV Protease Inhibitor for Treating Patients With Chronic Hepatitis C 7Schering-Plough Provides Update on Boceprevir Clinical Development and Introduces Potent Next-Generation Oral HCV Protease Inhibitor for Treating Patients With Chronic Hepatitis C 8Schering-Plough Provides Update on Boceprevir Clinical Development and Introduces Potent Next-Generation Oral HCV Protease Inhibitor for Treating Patients With Chronic Hepatitis C 9UCSF faculty receive 2413 7M from CIRM for stem cell research 25576 1UCSF faculty receive 2413 7M from CIRM for stem cell research 25576 2UCSF faculty receive 2413 7M from CIRM for stem cell research 25576 3Nurse Practitioner Healthcare Foundation Awards Scholarships to Leaders in Nursing 25574 1Nurse Practitioner Healthcare Foundation Awards Scholarships to Leaders in Nursing 25574 2Nurse Practitioner Healthcare Foundation Awards Scholarships to Leaders in Nursing 25574 3Nurse Practitioner Healthcare Foundation Awards Scholarships to Leaders in Nursing 25574 4VirtualHealth Technologies Inc Announces Its Associate Private Access Appoints Marc Kirshbaum as President 26 COO 25569 1VirtualHealth Technologies Inc Announces Its Associate Private Access Appoints Marc Kirshbaum as President 26 COO 25569 2VirtualHealth Technologies Inc Announces Its Associate Private Access Appoints Marc Kirshbaum as President 26 COO 25569 3VirtualHealth Technologies Inc Announces Its Associate Private Access Appoints Marc Kirshbaum as President 26 COO 25569 4VirtualHealth Technologies Inc Announces Its Associate Private Access Appoints Marc Kirshbaum as President 26 COO 25569 5VirtualHealth Technologies Inc Announces Its Associate Private Access Appoints Marc Kirshbaum as President 26 COO 25569 6VirtualHealth Technologies Inc Announces Its Associate Private Access Appoints Marc Kirshbaum as President 26 COO 25569 7New research on sexual function 25566 1New research on sexual function 25566 2
...ndicate early non-responders unlikely to subsequen...ts, and may benefit,from earlier change in treatme...07 /PRNewswire-FirstCall/,-- New data presented at...Research (ICOSR) suggest that antipsychotic drug,r...ght, and,challenge the current schizophrenia treat...
... Reduced By an Average of More Than Two Hours Per .../PRNewswire/ --,Adding the once daily, investigati...our(TM) Extended-Release Tablets to,Parkinson,s pa...cantly reduced ,off, time, allowing patients to co...of time. ,Off time,describes the return of Parkin...
Other Medicine Technology:New Data Show Early Non-Response to Antipsychotic Treatment May Be,Strong Predictor of Subsequent Non-Response for People with,Schizophrenia 2New Data Show Early Non-Response to Antipsychotic Treatment May Be,Strong Predictor of Subsequent Non-Response for People with,Schizophrenia 3New Data Show Early Non-Response to Antipsychotic Treatment May Be,Strong Predictor of Subsequent Non-Response for People with,Schizophrenia 4New Data Show Early Non-Response to Antipsychotic Treatment May Be,Strong Predictor of Subsequent Non-Response for People with,Schizophrenia 5New Data Show Early Non-Response to Antipsychotic Treatment May Be,Strong Predictor of Subsequent Non-Response for People with,Schizophrenia 6Once Daily, Extended-Release Ropinirole Improves Parkinson's,Symptoms in Patients not Optimally Controlled With Levodopa 2Once Daily, Extended-Release Ropinirole Improves Parkinson's,Symptoms in Patients not Optimally Controlled With Levodopa 3Once Daily, Extended-Release Ropinirole Improves Parkinson's,Symptoms in Patients not Optimally Controlled With Levodopa 4Once Daily, Extended-Release Ropinirole Improves Parkinson's,Symptoms in Patients not Optimally Controlled With Levodopa 5
...d for stone manipulation and removal in the urinar... to retain its shape following extreme torsion. Th...ture by allowing the basket to open at the base of...ign reduces the likelihood of mucosal damage and p...
Used to establish and maintain nephrostomy drainage following pyeloplasty. Supplied sterile in peel-open packages. Intended for one-time use. CAUTION: Periodic evaluation is advised; stent must not r
Used for percutaneous placement of a pigtail catheter in the renal pelvis for nephrostomy drainage. Supplied sterile in peel-open packages. Intended for one-time use. CAUTION: Periodic evaluation is
The BioPlex 2200 system is a fully automated bead-based multiplexing immunoassay platform that can deliver up to 2200 results per hour. The system will initially include a panel of assays targeting a
Medicine Products: